Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neelesh Sharma

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Applied Biochemistry and Biotechnology|June 29, 2016
Comparative Transcriptomic Analyses by RNA-seq to Elucidate Differentially Expressed Genes in the Muscle of Korean Thoroughbred HorsesMrinmoy Ghosh, Hyun-Woo Cho, Jeong-Woong Park, et al.
Nature Medicine|October 19, 2025
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trialTimothy A Yap, David J Kwiatkowski, Ibiayi Dagogo-Jack, et al.
Eclinicalmedicine|April 24, 2023
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 studyMarwan Fakih, Kanwal Pratap Singh Raghav, David Z Chang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2016
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016David S Ettinger, Douglas E Wood, Wallace Akerley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 14, 2016
NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016David S Ettinger, Douglas E Wood, Wallace Akerley, et al.
The Journal of Clinical Investigation|May 16, 2017
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growthJaya Sangodkar, Abbey Perl, Rita Tohme, et al.
Cancer Discovery|May 19, 2018
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung AdenocarcinomaFerdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Applied Biochemistry and Biotechnology|June 29, 2016
Comparative Transcriptomic Analyses by RNA-seq to Elucidate Differentially Expressed Genes in the Muscle of Korean Thoroughbred HorsesMrinmoy Ghosh, Hyun-Woo Cho, Jeong-Woong Park, et al.
Nature Medicine|October 19, 2025
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trialTimothy A Yap, David J Kwiatkowski, Ibiayi Dagogo-Jack, et al.
Eclinicalmedicine|April 24, 2023
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 studyMarwan Fakih, Kanwal Pratap Singh Raghav, David Z Chang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2016
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016David S Ettinger, Douglas E Wood, Wallace Akerley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 14, 2016
NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016David S Ettinger, Douglas E Wood, Wallace Akerley, et al.
The Journal of Clinical Investigation|May 16, 2017
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growthJaya Sangodkar, Abbey Perl, Rita Tohme, et al.
Cancer Discovery|May 19, 2018
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung AdenocarcinomaFerdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, et al.
Pageof 9